Vext Science Posts $14.9 Million in Q3 Revenue, Up 17.6%

Vext Science reported third-quarter revenue of $14.9 million, up 17.6% from a year earlier, as Ohio revenue grew and operating cash flow doubled from the previous quarter.

Ohio revenue reached $10.9 million, a 37% year-over-year increase. Fairfield and flower grown by the company led the state’s results.

Operating cash flow was $2.4 million, twice the Q2 2026 level, as inventory from the first half converted to cash. Vext posted a $4.9 million net loss and $0.2 million in adjusted EBITDA for the quarter. Year-to-date adjusted EBITDA was $6.4 million.